Physician profile
David Goldstein
NPI 1831119544
$17,453.22
in general payments reported to CMS, 2019-2025
10 companies · $855 in 2025
The $855 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,889 · 2020: $1,782 · 2021: $363 · 2022: $199 · 2023: $937 · 2024: $6,429 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $2,727 · Travel and Lodging: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $2,727.33 |
| Travel and Lodging | $992.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $11,681.62 | 2019-2025 | Fluency Endovascular Stent Graft, Covera, Venovo |
| Penumbra, INC. | $2,971.55 | 2019-2023 | Indigo System |
| Medtronic, INC. | $1,649.31 | 2020-2025 | Ellipsys Vascular Access System |
| Covidien Lp | $621.53 | 2020 | |
| Inari Medical, INC. | $234.12 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $208.52 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin |
| Mozarc Medical US LLC | $34.48 | 2023 | Chameleon |
| Boston Scientific Corporation | $19.91 | 2021 | |
| Biotronik INC. | $16.38 | 2023 | Pulsar-18 T3 |
| Cook Medical LLC | $15.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.